SECOND AMENDED AND RESTATED CREDIT AGREEMENT dated as of August 19, 2015 among ALBANY MOLECULAR RESEARCH, INC., as Borrower, THE LENDERS AND L/C ISSUERS FROM TIME TO TIME PARTY HERETO, BARCLAYS BANK PLC, as Administrative Agent, Collateral Agent, L/C...Credit Agreement • November 9th, 2015 • Albany Molecular Research Inc • Services-commercial physical & biological research • New York
Contract Type FiledNovember 9th, 2015 Company Industry JurisdictionThis Second Amended and Restated Credit Agreement (as may be amended, restated, amended and restated, supplemented or otherwise modified from time to time, this “Agreement”), is entered into as of August 19, 2015, by and among Albany Molecular Research, Inc., a Delaware corporation (the “Borrower”), the Lenders and L/C Issuers (each as hereinafter defined) from time to time party hereto and Barclays Bank PLC, as the Administrative Agent, the Collateral Agent, the Swing Line Lender (each as hereinafter defined) and a L/C Issuer.
AMENDMENT NO 1 TO SUPPLY AGREEMENT BETWEEN GE HEALTHCARE AS AND AMRI RENSSELAER, INC. FOR SUPPLY OF AMINOBISAMIDE HCL (“ABA HCL”) DATED SEPTEMBER 30, 2015Supply Agreement • November 9th, 2015 • Albany Molecular Research Inc • Services-commercial physical & biological research
Contract Type FiledNovember 9th, 2015 Company IndustryThis Amendment Number 1, (“First Amendment”) to the Supply Agreement between GE Healthcare AS (“GEHC”) and AMRI Rensselaer, Inc (the “Supplier”) for supply of ABA Hcl (the “Supply Agreement”).
FIRST AMENDED AND RESTATED CREDIT AGREEMENT dated as of July 16, 2015 among ALBANY MOLECULAR RESEARCH, INC., as Borrower, THE LENDERS AND L/C ISSUERS FROM TIME TO TIME PARTY HERETO, BARCLAYS BANK PLC, as Administrative Agent, Collateral Agent, L/C...Credit Agreement • November 9th, 2015 • Albany Molecular Research Inc • Services-commercial physical & biological research • New York
Contract Type FiledNovember 9th, 2015 Company Industry JurisdictionThis Amended and Restated Credit Agreement (as may be amended, restated, amended and restated, supplemented or otherwise modified from time to time, this “Agreement”), is entered into as of July 16, 2015, by and among Albany Molecular Research, Inc., a Delaware corporation (the “Borrower”), the Lenders and L/C Issuers (each as hereinafter defined) from time to time party hereto and Barclays Bank PLC, as the Administrative Agent, the Collateral Agent, the Swing Line Lender (each as hereinafter defined) and a L/C Issuer.